1. Home
  2. DOYU vs AVXL Comparison

DOYU vs AVXL Comparison

Compare DOYU & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DouYu International Holdings Limited ADS

DOYU

DouYu International Holdings Limited ADS

HOLD

Current Price

$3.55

Market Cap

134.3M

Sector

Technology

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

BUY

Current Price

$1.37

Market Cap

115.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
DOYU
AVXL
Founded
2014
2004
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.3M
115.9M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
DOYU
AVXL
Price
$3.55
$1.37
Analyst Decision
Hold
Analyst Count
4
0
Target Price
★ $4.78
N/A
AVG Volume (30 Days)
28.8K
★ 1.3M
Earning Date
11-19-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.43
$1.14
52 Week High
$7.23
$8.97

Technical Indicators

Market Signals
Indicator
DOYU
AVXL
Relative Strength Index (RSI) 26.71 27.14
Support Level N/A N/A
Resistance Level $4.90 $1.60
Average True Range (ATR) 0.21 0.12
MACD -0.05 0.01
Stochastic Oscillator 4.00 32.59

Price Performance

Historical Comparison
DOYU
AVXL

About DOYU DouYu International Holdings Limited ADS

DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company aims to build an integrated game-centric ecosystem of livestreaming, video, voice, graphic content, and other interactive and community features. The company operates the platform both on mobile apps and PC portals, through which users can enjoy immersive and interactive games and entertainment livestreaming, access a wide array of video and graphic content, and participate in community events and discussions.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: